Immunome Inc. SEC filings IMNM

Immunome Inc. has 460 filings in SEC EDGAR's recent list, going back to Sep 14, 2009. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 5, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.

Immunome Inc. SEC filings
Form Description Filed Period
SCHEDULE 13G Ownership over 5% (passive) Oct 30, 2026 —
8-K Current report
Material agreement, Unregistered share sale
Oct 5, 2026 Oct 2, 2026
4 Insider transaction Sep 15, 2026 Sep 11, 2026
144 Notice of proposed sale Sep 11, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
4 Insider transaction Aug 12, 2026 Aug 10, 2026
144 Notice of proposed sale Aug 12, 2026 —
S-8 Employee stock plan registration Aug 11, 2026 —
10-Q Quarterly report Aug 11, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 11, 2026 Aug 11, 2026
4 Insider transaction Aug 10, 2026 Aug 6, 2026
4 Insider transaction Aug 6, 2026 Aug 4, 2026
144 Notice of proposed sale Aug 6, 2026 —
144 Notice of proposed sale Aug 4, 2026 —
4 Insider transaction Jul 27, 2026 Jul 23, 2026
4 Insider transaction Jul 27, 2026 Jul 23, 2026
4 Insider transaction Jul 27, 2026 Jul 23, 2026
4 Insider transaction Jul 27, 2026 Jul 23, 2026
4 Insider transaction Jul 27, 2026 Jul 23, 2026
4 Insider transaction Jul 27, 2026 Jul 23, 2026
4 Insider transaction Jul 27, 2026 Jul 23, 2026
4 Insider transaction Jul 9, 2026 Jul 7, 2026
4 Insider transaction Jul 7, 2026 Jul 6, 2026
4 Insider transaction Jul 7, 2026 Jul 2, 2026
144 Notice of proposed sale Jul 7, 2026 —
144 Notice of proposed sale Jul 6, 2026 —
4 Insider transaction Jul 2, 2026 Jun 30, 2026
144 Notice of proposed sale Jul 2, 2026 —
144 Notice of proposed sale Jul 2, 2026 —
144 Notice of proposed sale Jun 30, 2026 —
144 Notice of proposed sale Jun 30, 2026 —
4 Insider transaction Jun 29, 2026 Jun 25, 2026
144 Notice of proposed sale Jun 25, 2026 —
4 Insider transaction Jun 17, 2026 Jun 15, 2026
144 Notice of proposed sale Jun 15, 2026 —
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
8-K Current report
Shareholder vote results
Jun 12, 2026 Jun 9, 2026
4 Insider transaction Jun 9, 2026 Jun 5, 2026
4 Insider transaction May 19, 2026 May 15, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 15, 2026 —
10-Q Quarterly report May 12, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 12, 2026 May 12, 2026
ARS Annual report to shareholders Apr 24, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 24, 2026 —
DEF 14A Proxy statement Apr 24, 2026 Jun 9, 2026
4 Insider transaction Apr 3, 2026 Apr 2, 2026
4 Insider transaction Apr 3, 2026 Apr 2, 2026
144/A Filing Apr 3, 2026 —
144 Notice of proposed sale Apr 2, 2026 —
144 Notice of proposed sale Apr 2, 2026 —
4 Insider transaction Apr 1, 2026 Mar 30, 2026
4 Insider transaction Mar 31, 2026 Mar 27, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
4 Insider transaction Mar 23, 2026 Mar 20, 2026
144 Notice of proposed sale Mar 20, 2026 —
4 Insider transaction Mar 12, 2026 Mar 10, 2026
S-8 Employee stock plan registration Mar 3, 2026 —
10-K Annual report Mar 3, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 3, 2026 Mar 3, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
4 Insider transaction Dec 30, 2025 Dec 30, 2025
4 Insider transaction Dec 23, 2025 Dec 22, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Dec 22, 2025 —
4 Insider transaction Dec 22, 2025 Dec 19, 2025
4 Insider transaction Dec 22, 2025 Dec 19, 2025
4 Insider transaction Dec 22, 2025 Dec 19, 2025
4 Insider transaction Dec 18, 2025 Dec 18, 2025
8-K Current report
Other events
Dec 17, 2025 Dec 16, 2025
424B5 Prospectus supplement Dec 17, 2025 —
424B5 Prospectus supplement Dec 15, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Dec 15, 2025 Dec 15, 2025
SCHEDULE 13G Ownership over 5% (passive) Nov 7, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 7, 2025 —
4 Insider transaction Sep 11, 2025 Sep 10, 2025
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 6, 2025 Aug 6, 2025
SCHEDULE 13G Ownership over 5% (passive) Aug 6, 2025 —
4 Insider transaction Jul 31, 2025 Jul 29, 2025
4 Insider transaction Jul 31, 2025 Jul 29, 2025
4 Insider transaction Jul 31, 2025 Jul 29, 2025
4 Insider transaction Jul 31, 2025 Jul 29, 2025
4 Insider transaction Jul 31, 2025 Jul 29, 2025
4 Insider transaction Jul 31, 2025 Jul 29, 2025
4 Insider transaction Jul 31, 2025 Jul 29, 2025
SCHEDULE 13G Ownership over 5% (passive) Jul 29, 2025 —
4 Insider transaction Jun 12, 2025 Jun 10, 2025
4 Insider transaction Jun 12, 2025 Jun 10, 2025
4 Insider transaction Jun 12, 2025 Jun 10, 2025
4 Insider transaction Jun 12, 2025 Jun 10, 2025
4 Insider transaction Jun 12, 2025 Jun 10, 2025
4 Insider transaction Jun 12, 2025 Jun 10, 2025
8-K Current report
Shareholder vote results
Jun 11, 2025 Jun 10, 2025
4 Insider transaction Jun 3, 2025 Jun 3, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2025 —
10-Q Quarterly report May 12, 2025 Mar 31, 2025
8-K Current report
Results of operations, Other events
May 12, 2025 May 8, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 12, 2025 —
ARS Annual report to shareholders Apr 24, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 24, 2025 —
DEF 14A Proxy statement Apr 24, 2025 Jun 10, 2025
4 Insider transaction Mar 28, 2025 Mar 27, 2025
4 Insider transaction Mar 26, 2025 Mar 25, 2025
4 Insider transaction Mar 26, 2025 Mar 26, 2025
4 Insider transaction Mar 25, 2025 Mar 24, 2025
4 Insider transaction Mar 25, 2025 Mar 24, 2025
S-8 Employee stock plan registration Mar 19, 2025 —
10-K Annual report Mar 19, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 19, 2025 Mar 19, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Feb 4, 2025 —
4 Insider transaction Feb 3, 2025 Jan 31, 2025
SCHEDULE 13G Ownership over 5% (passive) Feb 3, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 30, 2025 —
8-K Current report
Other events
Jan 30, 2025 Jan 29, 2025
424B5 Prospectus supplement Jan 30, 2025 —
424B5 Prospectus supplement Jan 29, 2025 —
8-K Current report
Results of operations, Other events
Jan 29, 2025 Jan 29, 2025
8-K Current report
Officer or director change
Jan 23, 2025 Jan 21, 2025
4 Insider transaction Nov 25, 2024 Nov 21, 2024
4 Insider transaction Nov 25, 2024 Nov 21, 2024
4 Insider transaction Nov 25, 2024 Nov 21, 2024
S-3ASR Automatic shelf registration Nov 22, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 13, 2024 Nov 13, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
SC 13G Ownership over 5% (passive) Nov 8, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 4, 2024 —
8-K Current report
Material agreement, Agreement ended, Acquisition or sale of assets, Unregistered share sale
Oct 29, 2024 Oct 25, 2024
SC 13G Ownership over 5% (passive) Oct 22, 2024 —
S-3ASR Automatic shelf registration Oct 8, 2024 —
8-K Current report
Other events
Oct 8, 2024 Oct 3, 2024
4 Insider transaction Sep 20, 2024 Sep 19, 2024
144 Notice of proposed sale Sep 19, 2024 —
SC 13D/A Amended ownership over 5% (active) Aug 21, 2024 —
4 Insider transaction Aug 19, 2024 Aug 15, 2024
4 Insider transaction Aug 19, 2024 Aug 15, 2024
144 Notice of proposed sale Aug 15, 2024 —
4 Insider transaction Aug 13, 2024 Aug 9, 2024
4 Insider transaction Aug 13, 2024 Aug 9, 2024
4 Insider transaction Aug 13, 2024 Aug 9, 2024
4 Insider transaction Aug 13, 2024 Aug 9, 2024
4 Insider transaction Aug 13, 2024 Aug 9, 2024
4 Insider transaction Aug 13, 2024 Aug 9, 2024
4 Insider transaction Aug 13, 2024 Aug 9, 2024
10-Q Quarterly report Aug 12, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 12, 2024 Aug 12, 2024
4 Insider transaction Jun 18, 2024 Jun 17, 2024
3 Initial insider ownership Jun 18, 2024 Jun 17, 2024
4 Insider transaction Jun 18, 2024 Jun 13, 2024
4 Insider transaction Jun 18, 2024 Jun 13, 2024
4 Insider transaction Jun 18, 2024 Jun 13, 2024
4 Insider transaction Jun 18, 2024 Jun 13, 2024
4 Insider transaction Jun 18, 2024 Jun 13, 2024
4 Insider transaction Jun 18, 2024 Jun 13, 2024
8-K Current report
Shareholder vote results
Jun 13, 2024 Jun 12, 2024
4 Insider transaction May 22, 2024 May 21, 2024
4 Insider transaction May 21, 2024 May 20, 2024
4 Insider transaction May 17, 2024 May 16, 2024
424B5 Prospectus supplement May 14, 2024 —
10-Q Quarterly report May 14, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 14, 2024 May 14, 2024
8-K Current report
Officer or director change
Apr 30, 2024 Apr 24, 2024
4 Insider transaction Apr 29, 2024 Apr 25, 2024
3 Initial insider ownership Apr 29, 2024 Apr 25, 2024
ARS Annual report to shareholders Apr 26, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Jun 12, 2024
8-K Current report
Officer or director change
Apr 25, 2024 Apr 25, 2024
S-3ASR Automatic shelf registration Apr 3, 2024 —
S-3ASR Automatic shelf registration Apr 3, 2024 —
10-K Annual report Mar 28, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 28, 2024 Mar 28, 2024
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Regulation FD disclosure
Mar 26, 2024 Mar 25, 2024
4 Insider transaction Feb 21, 2024 Feb 20, 2024
3 Initial insider ownership Feb 21, 2024 Feb 12, 2024
8-K Current report
Other events
Feb 14, 2024 Feb 13, 2024
424B5 Prospectus supplement Feb 14, 2024 —
424B5 Prospectus supplement Feb 13, 2024 —
8-K Current report
Results of operations, Other events
Feb 13, 2024 Feb 13, 2024
S-3ASR Automatic shelf registration Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 12, 2024 —
SC 13G Ownership over 5% (passive) Feb 9, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Feb 6, 2024 Feb 5, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
IMNM (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Bothell, WA
SEC filer status
Non-accelerated filer
SEC CIK
1472012

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.